Mitrabahtera Segara Sejati Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Mitrabahtera Segara Sejati Tbk. trades at Rp2,890 (market cap 5.04T, 2.48M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume). The key difference: Mitrabahtera Segara Sejati Tbk. is far larger — about 11.8× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (13.83M versus 2.48M). Which is the better fit depends on your goals.
| MBSS | PRDL | |
|---|---|---|
Market Cap | 5.04T | 428.75B |
Volume | 2.48M | 13.83M |
Lot | 24.83K | 138.27K |
Turnover | 7.17B | 3.27B |
Average Price | 2,888.23 | 236.62 |
Value | 7.17B | 3.27B |
Indicative Equilibrium Price | 2,890 | 236 |
Indicative Equilibrium Volume | 783 | 1.74K |
Trailing returns across standard periods
Latest headlines on both assets
PT Mitrabahtera Segara Sejati Tbk (the company) was established on 24 Mar 1994 based on Notaries Deed No. 107 and the deed of establishment was approved by the the Ministry of Justice dated Nov 6, 1996. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Fathiah Helmi, S.H., dated Dec 13, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on MBSS →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →